• Study Comparing ONC-392 and Docetaxel for Patients with Metastatic Non-Small Cell Lung Cancer After PD-1/PD-L1 Treatment

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Belgium Germany Italy Spain
  • Study on Iron Infusion with Ferric Carboxymaltose for Elderly Patients with Severe Aortic Stenosis and Iron Deficiency Undergoing TAVI

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands
  • Study of NMS-03305293 and Temozolomide for Adults with Recurrent Glioblastoma

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy The Netherlands
  • Study of Dasatinib for Patients with Acute Myeloid Leukemia Not Responding to Venetoclax-Azacitidine Treatment

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • Study on the Effects and Safety of Cemiplimab and BNT116 in Adults with Advanced Non-Small Cell Lung Cancer

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    Germany Poland Spain
  • Study Comparing Ivonescimab and Chemotherapy with Pembrolizumab and Chemotherapy for Patients with Metastatic Squamous Non-small Cell Lung Cancer

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    France Germany Greece Ireland Italy Poland +1
  • Study on the Safety and Tolerability of Higher Dose Rifampicin for Tuberculosis Patients

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    Denmark Italy The Netherlands
  • Study on Alnuctamab and Mezigdomide for Patients with Relapsed or Refractory Multiple Myeloma

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    Denmark
  • Study Comparing Sodium Chloride and Lactated Ringer’s Solution for Patients with Acute Pancreatitis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    France Spain
  • Study on Cannabidiol for Joint Pain in Early Breast Cancer Patients on Hormone Therapy

    Not yet recruiting

    3 1
    Investigated Drugs:
    France

powered by